essentiapharm
Patient relationship management and compliance is perhaps more important today than at any previous time. Disease awareness services, patient support and compliance programmes demand experienced and knowledgeable delivery.
It’s notable that recent reports have shown GPs to be more likely to prescribe drugs which are supported by a helpline service. That’s no coincidence. They recognise the value of helplines in supporting their delivery of patient care.
We can provide meaningful information to patients and lessen their confusion about their treatment, leading to increased understanding and therefore compliance, as well as reinforcing other lifestyle behavioural changes.
Better still, our clients can utilise our ability in developing databases and intelligent reporting systems which in turn, results in meaningful marketing intelligence reports.
A dedicated, stand-alone division, the essentiapharm remit is to offer the pharmaceutical industry the very best in terms of response solutions.
We'll work with you to shape your service, whether it involves clinical trial recruitment, compliance, education, product information, patient profiling or signposting.
Speak to us. We will work with you to define the programme you need to create. We will speak to your target audience and help increase your understanding of them.
We'll work with you to shape your service, whether it involves clinical trial recruitment, compliance, education, product information, patient profiling or signposting.
As for integrated communication mechanisms, these are tailored to your patients or other target groups in their preferred format, be that SMS, webchat, email, fax, post and of course, telephone.
Speak to us. We will work with you to define the programme you need to create. We will speak to your target audience and help increase your understanding of them.
As a service to the industry, essentiapharm is currently sponsoring the publication of the Keword Pharma Expert Review on Patient Compliance and the Need for Technologies, looking at the ramifications of non-compliance and how new interactive technologies can tackle the issue.
